Edition:
United States

Daxor Corp (DXR.A)

DXR.A on American Stock Exchange

8.64USD
14 Feb 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$8.64
Open
--
Day's High
--
Day's Low
--
Volume
91
Avg. Vol
743
52-wk High
$9.80
52-wk Low
$7.25

DXR.A

Chart for DXR.A

About

Daxor Corporation is an investment company with medical instrumentation and biotechnology operations. The Company engages in the short selling of stock. The Company maintains a diversified securities portfolio, which consists primarily of the common and preferred stocks of electric utility companies. It has approximately 70... (more)
No analyst recommendations are available for DXR.A.

Overall

Beta: 0.13
Market Cap(Mil.): $34.05
Shares Outstanding(Mil.): 3.83
Dividend: 0.03
Yield (%): 0.34

Financials

  DXR.A Industry Sector
P/E (TTM): -- 52.89 29.35
EPS (TTM): -0.80 -- --
ROI: -14.58 7.57 12.97
ROE: -17.02 11.40 14.11

BRIEF-Daxor Corp appointed Michael Feldschuh as CEO

* On September 21, 2016 board appointed Michael Feldschuh as permanent president and CEO of co - SEC filing

Sep 23 2016

More From Around the Web

Earnings vs. Estimates